nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.10.2015 | Review – Clinical Oncology

Height and kidney cancer risk: a meta-analysis of prospective studies

verfasst von: Sudong Liang, Gaofei Lv, Weikai Chen, Jianxin Jiang, Jingqun Wang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to perform a meta-analysis to summarize the available evidence from prospective studies on the association between height and kidney cancer risk.

Methods

Relevant studies were identified through the MEDLINE and EMBASE databases up to July 2014, as well as through the references from the retrieved articles. Relative risks (RRs) from individual studies were pooled by using a random-effects model.

Results

A total of fourteen prospective studies of adult height and kidney cancer risk with 18,766 cases were included in the meta-analysis. Overall, per 10-cm increase in height was associated with an increased risk of kidney cancer (RR 1.23; 95 % confidence interval 1.18–1.28, I ² = 11.8 %). Subgroup analysis showed a basically consistent result with the overall analysis. There was no evidence of publication bias.

Conclusions

High adult height was positively associated with the risk of kidney cancer in both men and women in this meta-analysis. Future prospective studies are needed to determine the generalizability of these findings to non-Caucasians.

Adams KF, Leitzmann MF, Albanes D, Kipnis V, Moore SC, Schatzkin A, Chow W-H (2008) Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol 168:268–277PubMedCentralPubMed

Marmot M et al (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective

Aune D et al (2012) Height and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies. Cancer Causes Control 23:1213–1222CrossRefPubMed

Batty G, Shipley M, Langenberg C, Marmot M, Smith GD (2006) Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study. Ann Oncol 17:157–166CrossRefPubMed

Batty G et al (2010) Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration Annals of oncology 21:646–654PubMed

Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 1088–1101

Ben-Shlomo Y, Holly J, McCarthy A, Savage P, Davies D, Smith GD (2005) Prenatal and postnatal milk supplementation and adult insulin-like growth factor I: long-term follow-up of a randomized controlled trial. Cancer Epidemiol Biomark Prev 14:1336–1339CrossRef

Bjørge T, Tretli S, Engeland A (2004) Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160:1168–1176CrossRefPubMed

Cheung CW, Vesey DA, Nicol DL, Johnson DW (2004) The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int 65:1272–1279CrossRefPubMed

Chow W-H, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer Nature Reviews. Urology 7:245–257PubMedCentralPubMed

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials controlled clinical trials 7:177–188CrossRefPubMed

Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMedCentralCrossRefPubMed

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRefPubMed

Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V (2011) Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 12:785–794PubMedCentralCrossRefPubMed

Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose–response data, with applications to meta-analysis. Am J Epidemiol 135:1301–1309PubMed

Hamling J, Lee P, Weitkunat R, Ambühl M (2008) Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 27:954–970CrossRefPubMed

Higgins J, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefPubMed

Kabat GC et al (2013a) Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomark Prev 22:1353–1363CrossRef

Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE (2013b) Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 132:1125–1132CrossRefPubMed

Major J, Pollak M, Snyder K, Virtamo J, Albanes D (2010) Insulin-like growth factors and risk of kidney cancer in men. Br J Cancer 103:132–135PubMedCentralCrossRefPubMed

Pischon T et al (2006) Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 118:728–738CrossRefPubMed

Rasmuson T, Grankvist K, Jacobsen J, Olsson T, Ljungberg B (2004) Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Acta Oncol 43:744–748CrossRefPubMed

Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353CrossRefPubMed

Rogers I, Metcalfe C, Gunnell D, Emmett P, Dunger D, Holly J (2006) Insulin-like growth factor-I and growth in height, leg length, and trunk length between ages 5 and 10 years. J Clin Endocrinol Metab 91:2514–2519CrossRefPubMed

Setiawan VW, Stram DO, Nomura AM, Kolonel LN, Henderson BE (2007) Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol 166:932–940CrossRefPubMed

Silventoinen K (2003) Determinants of variation in adult body height. J Biosoc Sci 35:263–285CrossRefPubMed

Stewart AL (1982) The reliability and validity of self-reported weight and height. J Chronic Dis 35:295–309CrossRefPubMed

Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283:2008–2012CrossRefPubMed

Tang R-Q, Zheng W, Li H-L, Gao Y-T, Shu X-O, Xiang Y-B (2012) Prospective cohort study of body height and cancer incidence among adult men and women in Shanghai. Tumor 32:992–1000

Tripaldi R, Stuppia L, Alberti S (2013) Human height genes and cancer. Biochim Biophys Acta Rev Cancer 1836:27–41CrossRef

Tulinius H, Sigfússon N, Sigvaldason H, Bjarnadóttir K, Tryggvadottir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomark Prev 6:863–873

Van Dijk BA, Schouten LJ, Kiemeney LA, Goldbohm RA, Van den Brandt PA (2004) Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study. Am J Epidemiol 160:1159–1167CrossRefPubMed

Walter RB, Brasky TM, Buckley SA, Potter JD, White E (2013) Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst 105:860–868PubMedCentralCrossRefPubMed

Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses

Wirén S et al (2014) Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 25:151–159PubMedCentralCrossRefPubMed

Zuccolo L et al (2008) Height and prostate cancer risk: a large nested case–control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomark Prev 17:2325–2336CrossRef

Titel: Height and kidney cancer risk: a meta-analysis of prospective studies
verfasst von: Sudong Liang
Gaofei Lv
Weikai Chen
Jianxin Jiang
Jingqun Wang
Publikationsdatum: 01.10.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 10/2015
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-014-1870-5

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Height and kidney cancer risk: a meta-analysis of prospective studies

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2015

p53 target gene Rap2B regulates the cytoskeleton and inhibits cell spreading

Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis

Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties

Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers

F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie